ArticleBMC neurology2025

Efgartigimod for treating Guillain-Barré syndrome with poor response to intravenous immunoglobulin: a case report.

Bai Qi Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.